Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2026-02-28 @ 7:28 AM
Study NCT ID:
NCT00546104
Status:
COMPLETED
Last Update Posted:
2013-07-17
First Post:
2007-10-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Dasatinib Study in Advanced Breast Cancer
Sponsor:
Duke University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Breast Cancer | View |